Skip to Main Content

Contribute Try STAT+ Today

Exclusive

Most Read

Blue AI pill

Exclusive By Katie Palmer

Alphabet has a new drug discovery company building on DeepMind’s AI chops

funding illo

Exclusive By Erin Brodwin

Cityblock Health raises another mega-round of funding, tipping its valuation over $5 billion

Exclusive By Olivia Goldhill

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

Biogen Aduhelm illo

Exclusive By Adam Feuerstein, Matthew Herper and Damian Garde

Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug

3/1 Trump

Exclusive By Rachel Cohrs

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

Pfizer BioNTech vaccine

Exclusive By Olivia Goldhill

Covid-19 vaccination rates follow the money in states with the biggest wealth gaps, analysis shows

Johnson & Johnson sign

Exclusive By Matthew Herper

Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Pascal Soriot 2019

Exclusive By Adam Feuerstein

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

All Coverage

Priscilla Chan

Exclusive By Katie Palmer

‘A multi-decade journey’: Chan Zuckerberg Initiative invests another $3.4 billion to advance scientific tools

2019 PET scan

Exclusive By Kate Sheridan

Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s

advertisement

Ascension St. Vincent'

Exclusive By Rachel Cohrs

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

N. Pelosi

Exclusive By Rachel Cohrs

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Sen. Wyden

Exclusive By Rachel Cohrs and Nicholas Florko

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Lactated Ringer's solution

Exclusive By Adam Feuerstein and Damian Garde

Biogen’s Aduhelm sales slower than disclosed, forcing company to consider cost-cutting measures

Sen. Ron Wyden

Exclusive By Rachel Cohrs

Senate proposes expanding pharma penalties for hiking drug prices

U.S. Capitol

Exclusive By Nicholas Florko and Rachel Cohrs

Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates

BIO rebuild

Exclusive By Nicholas Florko

‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby

one hundred dollar bills

Exclusive By Kate Sheridan

Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms

yellow background iv bag

Exclusive By Damian Garde

Sesen Bio trial of cancer drug marked by misconduct and worrisome side effects, documents show

Aubrey de Grey

Exclusive By Megan Molteni

Anti-aging foundation’s CEO left amid an investigation of co-founder Aubrey de Grey

Leen Kawas-Athira

Exclusive By Olivia Goldhill

Athira cited altered studies in $15 million NIH grant application, creating legal risk

Virus Outbreak Kids Heart Inflammation

Exclusive By Nicholas Florko

FDA, under pressure, plans ‘sprint’ to accelerate review of Pfizer’s Covid-19 vaccine for full approval

insulin biosimilar

Exclusive By Nicholas Florko, Ed Silverman, Rachel Cohrs and Damian Garde

FDA’s expansive Alzheimer’s drug approval surprised even top agency officials

Dr. Neel Shah

Exclusive By Erin Brodwin

In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’

Gustave Perna

Exclusive By Nicholas Florko

Perna set to retire from Warp Speed later this summer

Leen Kawas WSU

Exclusive By Olivia Goldhill

Athira Pharma CEO placed on leave amid allegations of altered images in her research papers

Covid swab UK

Exclusive By Kathleen McLaughlin

FDA accuses company of distributing unapproved Covid test and using falsified data

Erich Huang

Exclusive By Erin Brodwin

Onduo’s new exec on Google’s data skills, real-world evidence, and moving the needle on outcomes

digital diabetes care

Exclusive By Erin Brodwin

Carbon Health dives into digital diabetes care with virtual clinic acquisition

King Shkreli

Exclusive By Adam Feuerstein and Damian Garde

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Exclusive By Olivia Goldhill and Rachel Cohrs

Boxed in: How a single Pfizer decision complicated the Covid vaccine rollout while boosting profits

RNA illustration

Exclusive By Megan Molteni and Katie Palmer

From two unusual organ donations, scientists garner a unique trove of single-cell genetic data

Kelvin Droegemeier

Exclusive By Nicholas Florko

Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews